Application | Comment | Organism |
---|---|---|
pharmacology | pharmacological targeting of the enzyme may have important therapeutic benefits in disease mechanisms that involve excessive cell proliferation, in particular, cancer and proliferative glomerulopathies | Mus musculus |
pharmacology | pharmacological targeting of the enzyme may have important therapeutic benefits in disease mechanisms that involve excessive cell proliferation, in particular, cancer and proliferative glomerulopathies | Danio rerio |
Localization | Comment | Organism | GeneOntology No. | Textmining |
---|---|---|---|---|
cytosol | - |
Mus musculus | 5829 | - |
cytosol | - |
Danio rerio | 5829 | - |
Organism | UniProt | Comment | Textmining |
---|---|---|---|
Danio rerio | P50392 | - |
- |
Mus musculus | P47713 | - |
- |
Source Tissue | Comment | Organism | Textmining |
---|---|---|---|
brain | embryo, developing brain. The enzyme is moderately expressed in a cell cluster restricted to the forebrain and hindbrain with a clearer and more intense signal in the otic vesicles | Danio rerio | - |
fibroblast | embryonic | Mus musculus | - |
mesangial cell | - |
Mus musculus | - |
Synonyms | Comment | Organism |
---|---|---|
cPLA2alpha | - |
Mus musculus |
cPLA2alpha | - |
Danio rerio |
phospholipase A2alpha | - |
Mus musculus |
phospholipase A2alpha | - |
Danio rerio |
Organism | Comment | Expression |
---|---|---|
Danio rerio | the transcript is readily detectable at 12 h postfertilization and continues to be expressed at similar level until 72 h, after which the expression declines dramatically. Protein expression is detectable at 12 h, with peak expression occurring between 24 and 34 h postfertilization | up |
General Information | Comment | Organism |
---|---|---|
malfunction | lack of cPLA2alpha prolongs the G1 phase and reduces the proliferating capacity in response to mitogen stimulation without a significant change in the duration of the other phases of the cell cycle | Mus musculus |
malfunction | loss of cpla2a expression or inhibition of cpla2a activity diminishes G1 progression through the cell cycle | Danio rerio |
metabolism | through its phospholipase activity, the enzyme is a critical effector ofG1 phase progression through the cell cycle | Danio rerio |
physiological function | cpla2a genes play an important role in the development of the brain region | Danio rerio |
physiological function | the enzyme is a key mediator of inflammation and tumorigenesis | Danio rerio |
physiological function | the enzyme plays an important role in induction of cell cycle progression at the G1 phase in mesangial cells through inhibition of FOXO1 activity | Mus musculus |